Samuel Gebhardt

3PUBLICATIONS
25CO-AUTHORS
Molecular targetsHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 15, 2026
Precision modeling of tumor antigen-specific T-cell responses in humanized mice for preclinical assessment of cancer immunotherapies.

|Aug 01, 2025
Preclinical advances in glofitamab combinations: a new frontier for non-Hodgkin lymphoma.

Johannes Sam, Gabrielle Leclercq-Cohen, Samuel Gebhardt

|Mar 04, 2024
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy.

Johannes Sam, Thomas Hofer, Christine Kuettel

Pageof 1

Frequent Collaborators

2 joint publications

Johannes Sam

2 joint publications

Sylvia Herter

2 joint publications

Christian Klein

2 joint publications

Marina Bacac